ARS

AUTO-GENERATED PAPER DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: October 22, 2014
Period of Report: December 31, 2013
Accession Number: 9999999997-14-014527

View Document ↗ View on SEC.gov ↗